THROMBIN-JMI is a Kit in the Plasma Derivative category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is .
Product ID | 60793-215_00e463ff-bc0c-45d7-944f-5275c814c428 |
NDC | 60793-215 |
Product Type | Plasma Derivative |
Proprietary Name | THROMBIN-JMI |
Generic Name | Thrombin, Topical (bovine) |
Dosage Form | Kit |
Marketing Start Date | 1995-02-24 |
Marketing Category | BLA / BLA |
Application Number | BLA102865 |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1995-02-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA102865 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 1995-02-24 |
NDC | Brand Name | Generic Name |
---|---|---|
60793-205 | THROMBIN-JMI | thrombin, topical (bovine) |
60793-215 | THROMBIN-JMI | thrombin, topical (bovine) |
60793-217 | THROMBIN-JMI | thrombin, topical (bovine) |
60793-705 | THROMBIN-JMI | thrombin, topical (bovine) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
THROMBIN-JMI 78468722 not registered Dead/Abandoned |
King Pharmaceuticals, Inc. 2004-08-17 |
THROMBIN-JMI 74650513 2044605 Live/Registered |
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, LLC 1995-03-23 |